Vanguard Personalized Indexing Management, LLC Tg Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 10,092 shares of TGTX stock, worth $354,431. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,092
Previous 10,075
0.17%
Holding current value
$354,431
Previous $397,000
8.56%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding TGTX
# of Institutions
408Shares Held
91.9MCall Options Held
2.28MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA15.8MShares$555 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$400 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$268 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$123 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$107 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.1B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...